Candelanza, Janice B.
HRN: 06-29-32 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
CEFUROXIME 750MG (VIAL)
07/22/2023
07/29/2023
IVT
750mg
Q8
UTI
Waiting Final Action